With the introduction of advanced sequencing methodologies (next-generation sequencing, NGS) that allowed the deep sequencing of the larger portion of the genome, the role of somatic RET mutations as main drivers in MTC had been confirmed. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.